• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Shockwave Medical, Inc. - Common Stock (NQ:SWAV)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Shockwave Medical, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
This Stock Is Up 106% In 2022 And Analysts Love It, But Jim Cramer Says 'There's Too Much Political Risk' ↗
November 15, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rocket Pharmaceuticals Inc (NASDAQ: RCKT) is a "very early stage company that has a lot in the pipe. I tend to like these companies." 
Via Benzinga
News headline image
2 Stocks I'd Buy Right Now Without Hesitation ↗
November 13, 2022
One's a growth stock and the other pays a dividend but both of these healthcare businesses have what it takes to reliably outperform. 
Via The Motley Fool
News headline image
Stock Market Rally Roars Higher On Cooling Inflation; Bitcoin, Meta, Tesla In Focus: Weekly Review ↗
November 11, 2022
Bitcoin hit a two-year low while Meta and Tesla were in focus. 
Via Investor's Business Daily
News headline image
Here's the Best Growth Stock to Buy Right Now If You're Worried About a Recession ↗
November 09, 2022
Macroeconomic pressures aren't much of an issue when all your customers are cardiovascular surgeons. 
Via The Motley Fool
News headline image
ShockWave Medical (SWAV) Q3 2022 Earnings Call Transcript ↗
November 07, 2022
SWAV earnings call for the period ending September 30, 2022. 
Via The Motley Fool
News headline image
Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday ↗
November 08, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Where ShockWave Medical Stands With Analysts ↗
November 08, 2022
Over the past 3 months, 4 analysts have published their opinion on ShockWave Medical (NASDAQ:SWAV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
News headline image
Shockwave Medical Reports Third Quarter 2022 Financial Results
November 07, 2022
From Shockwave Medical, Inc.
Via GlobeNewswire
News headline image
Earnings Preview: ShockWave Medical ↗
November 04, 2022
ShockWave Medical (NASDAQ:SWAV) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that ShockWave... 
Via Benzinga
News headline image
Earnings Scheduled For November 7, 2022 ↗
November 07, 2022
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million. 
Via Benzinga
News headline image
Best and Worst Performing Stocks Since Rate Hikes Began ↗
November 02, 2022
Looking at the S&P 1500, which includes large-caps, mid-caps, and small-caps, the average stock in the index is down 7.1% since the close on March 16th after the first rate hike. 
Via Talk Markets
News headline image
Shockwave Confirms Consistent Outcomes for IVL in the Largest Prospective “Real World” Study of Patients with Heavily Calcified Peripheral Arterial Disease
November 01, 2022
Disrupt PAD III Observational Study Results Confirm Safety and Effectiveness of IVL in Patients with Complex Calcified Lesions 
From Shockwave Medical, Inc.
Via GlobeNewswire
News headline image
Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest ↗
October 28, 2022
Although "Big Tech" is currently struggling, but there are still many good top tech stocks to buy at this point. 
Via InvestorPlace
News headline image
Nasdaq Bear Market: 3 Growth Stocks You'll Regret Not Buying at Knocked-Down Prices ↗
October 25, 2022
Scooping up shares of these fast-growing businesses on the dip could do wonders for your portfolio over time. 
Via The Motley Fool
News headline image
Opportunities In Large Cap Growth And Small Cap ↗
October 20, 2022
The third quarter was true 
Via Talk Markets
News headline image
Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2022 Results
October 20, 2022
From Shockwave Medical, Inc.
Via GlobeNewswire
News headline image
7 Little-Known Stocks With Millionaire-Maker Potential ↗
October 14, 2022
The unprecedented number of tech revolutions has made it easier than ever to identify many potential millionaire-maker stocks to buy. 
Via InvestorPlace
News headline image
Eli Lilly Leads 5 Stocks To Watch In Bear Market ↗
October 08, 2022
Eli Lilly is holding up, while others crumbled Friday amid the market sell-off. 
Via Investor's Business Daily
News headline image
2 Medical Device Makers Crushing the Market ↗
October 06, 2022
One company is an industry disruptor with big upside potential, while the other is a huge, diversified company. 
Via The Motley Fool
News headline image
Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year ↗
October 05, 2022
Biotech isn't the only place to make money in health care this year. 
Via Investor's Business Daily
News headline image
Cutera Stock Earns Relative Strength Rating Upgrade ↗
October 03, 2022
On Monday, medical aesthetic Cutera stock had its Relative Strength (RS) Rating upgraded to 90 from 80 a day earlier. 
Via Investor's Business Daily
News headline image
Expert Ratings for ShockWave Medical ↗
August 29, 2022
Over the past 3 months, 5 analysts have published their opinion on ShockWave Medical (NASDAQ:SWAV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
News headline image
Ulta Beauty To $511? Here Are 5 Other Price Target Changes For Monday ↗
August 29, 2022
Barclays boosted the price target on Ulta Beauty, Inc. (NASDAQ: ULTA) from $491 to $511. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Ulta Beauty shares fell 1% to... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022 ↗
September 06, 2022
Upgrades 
Via Benzinga
News headline image
ShockWave Stuns With 40% Post-Earnings Price Move: Is It A Buy?
August 25, 2022
Shockwave Medical bolted 40% higher since its second-quarter earnings report on August 8. It's currently trading at new highs, but is it the right time to buy? 
Via MarketBeat
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
August 12, 2022
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review ↗
August 12, 2022
The major indexes continued to advance, despite some key warnings. 
Via Investor's Business Daily
News headline image
InMode Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold ↗
August 09, 2022
On Tuesday, InMode stock got a positive adjustment to its Relative Strength (RS) Rating, to 86 from 72 a day earlier. 
Via Investor's Business Daily
News headline image
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
News headline image
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session ↗
August 09, 2022
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap